Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuro Nishimura

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 9, 2018
Comparison of patients with hepatic encephalopathy and those with gastric varices before and after balloon-occluded retrograde transvenous obliterationTsuyoshi Ishikawa, Ryo Sasaki, Tatsuro Nishimura, et al.
Journal of Gastroenterology|December 30, 2022
A combination of liver stiffness and international normalized ratio is an ideal prognostic predictor of portosystemic shunt occlusion in patients with portal hypertensionTsuyoshi Ishikawa, Maho Egusa, Tsuyoshi Fujioka, et al.
Plos One|January 24, 2019
Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis modelTatsuro Nishimura, Taro Takami, Ryo Sasaki, et al.
Plos One|January 20, 2026
Development of a novel scoring system to determine the optimal timing of esophagogastroduodenoscopy following portosystemic shunt occlusionTatsuro Nishimura, Aika Kirihara, Maho Egusa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 7, 2025
Caution Regarding Short-Term Increases in Ammonia Levels Following Splenic Artery EmbolizationTsuyoshi Ishikawa, Aika Kirihara, Natsuko Nishiyama, et al.
Hepatology Communications|February 7, 2018
A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow-derived cellsTakashi Matsuda, Taro Takami, Ryo Sasaki, et al.
Oncology|January 29, 2024
Varying Impact of Lenvatinib or Sorafenib Therapy on Skeletal Muscle Loss in Patients with Hepatocellular CarcinomaYurika Yamauchi, Issei Saeki, Koichi Fujisawa, et al.
Hepatology International|May 15, 2023
Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinomaIssei Saeki, Yutaka Suehiro, Yurika Yamauchi, et al.
Cancers|June 10, 2023
Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular CarcinomaNorikazu Tanabe, Issei Saeki, Yuki Aibe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2023
Double cancer of primary hepatic angiosarcoma and hepatocellular carcinoma treated with atezolizumab plus bevacizumabYurika Yamauchi, Issei Saeki, Takahiro Yamasaki, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 9, 2018
Comparison of patients with hepatic encephalopathy and those with gastric varices before and after balloon-occluded retrograde transvenous obliterationTsuyoshi Ishikawa, Ryo Sasaki, Tatsuro Nishimura, et al.
Journal of Gastroenterology|December 30, 2022
A combination of liver stiffness and international normalized ratio is an ideal prognostic predictor of portosystemic shunt occlusion in patients with portal hypertensionTsuyoshi Ishikawa, Maho Egusa, Tsuyoshi Fujioka, et al.
Plos One|January 24, 2019
Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis modelTatsuro Nishimura, Taro Takami, Ryo Sasaki, et al.
Plos One|January 20, 2026
Development of a novel scoring system to determine the optimal timing of esophagogastroduodenoscopy following portosystemic shunt occlusionTatsuro Nishimura, Aika Kirihara, Maho Egusa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 7, 2025
Caution Regarding Short-Term Increases in Ammonia Levels Following Splenic Artery EmbolizationTsuyoshi Ishikawa, Aika Kirihara, Natsuko Nishiyama, et al.
Hepatology Communications|February 7, 2018
A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow-derived cellsTakashi Matsuda, Taro Takami, Ryo Sasaki, et al.
Oncology|January 29, 2024
Varying Impact of Lenvatinib or Sorafenib Therapy on Skeletal Muscle Loss in Patients with Hepatocellular CarcinomaYurika Yamauchi, Issei Saeki, Koichi Fujisawa, et al.
Hepatology International|May 15, 2023
Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinomaIssei Saeki, Yutaka Suehiro, Yurika Yamauchi, et al.
Cancers|June 10, 2023
Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular CarcinomaNorikazu Tanabe, Issei Saeki, Yuki Aibe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2023
Double cancer of primary hepatic angiosarcoma and hepatocellular carcinoma treated with atezolizumab plus bevacizumabYurika Yamauchi, Issei Saeki, Takahiro Yamasaki, et al.
Pageof 2